ArticleMolecular therapy. Oncology2026

Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety.

Yuki Sakashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.